首页> 外文期刊>In Practice >Soft tissue sarcoma in the dog: an update
【24h】

Soft tissue sarcoma in the dog: an update

机译:狗的软组织肉瘤:更新

获取原文
获取原文并翻译 | 示例
           

摘要

Soft tissue sarcomas (STS) are a large group of tumours derived from mesenchymal tissues. STS may arise anywhere in the body, but most commonly appear on the appendicular skeleton. They typically present as a firm, discrete and expansile mass. They can present the clinician with significant challenges with respect to management. When treated appropriately, the prognosis for the majority of dogs is good, provided a complete resection has been achieved. However, about 20 to 30 per cent of dogs may ultimately die of their disease due to unresectable local recurrence or metastatic disease. Surgery is the mainstay for the treatment of STS, but inclusion of radiation therapy may allow for a reduction in surgical margins, or the control of incomplete resections. A role for chemotherapy remains unclear. This article reviews the diagnostic and treatment options available for STS, and seeks to improve awareness of the many questions and uncertainties that remain with regards to their management.
机译:软组织肉瘤(STS)是来自间充质组织的一大群肿瘤。 STS可能在身体的任何地方出现,但最常出现在附奇骨架上。 它们通常作为坚定的,离散和扩大的质量存在。 他们可以介绍临床医生对管理层具有重大挑战。 当适当治疗时,大多数狗的预后都很好,提供了完全切除的术语。 然而,由于局部复发或转移性疾病,大约20%至30%的狗可能最终死于疾病。 手术是治疗STS的主干,但包含放射治疗的包容可能允许减少手术边缘或对不完全切除的控制。 化学疗法的作用仍然不清楚。 本文审查了STS可用的诊断和治疗方案,并寻求提高对其管理层仍然存在的许多问题和不确定性的认识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号